Vania Vidimar
0000-0002-2568-0941
5 papers found
Refreshing results…
Supplementary Figure from Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts
Data from Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts
Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts
RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines
An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth
Missing publications? Search for publications with a matching author name.